UPDATE: JP Morgan Initiates Progyny With Overweight, $26 Target Notes Co's 'Delivering a Differentiated Approach to Fertility Benefits'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · 11/19/2019 15:41